D Raichvarg

1.2k total citations
61 papers, 995 citations indexed

About

D Raichvarg is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, D Raichvarg has authored 61 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 11 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in D Raichvarg's work include Immune Response and Inflammation (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). D Raichvarg is often cited by papers focused on Immune Response and Inflammation (11 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). D Raichvarg collaborates with scholars based in France, Senegal and Morocco. D Raichvarg's co-authors include M Roch-Arveiller, Guillaume Lefèvre, M. F. Huyghebaert, J. F. Dhainaut, J F Monsallier, Fabrice Brunet, M.-P. Vasson, A Carli, D. Villemant and J Dall'Ava-Santucci and has published in prestigious journals such as Circulation, Infection and Immunity and Clinical Chemistry.

In The Last Decade

D Raichvarg

60 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Raichvarg France 16 260 169 162 161 157 61 995
E. N. Wardle United Kingdom 18 177 0.7× 139 0.8× 198 1.2× 292 1.8× 124 0.8× 108 1.1k
Roger C. Bone United States 7 408 1.6× 137 0.8× 65 0.4× 152 0.9× 359 2.3× 8 1.1k
Roy D. Goldfarb United States 15 297 1.1× 117 0.7× 45 0.3× 129 0.8× 155 1.0× 39 778
Jean-Daniel Baumgartner Switzerland 9 629 2.4× 135 0.8× 70 0.4× 154 1.0× 419 2.7× 13 1.2k
R. Urbaschek Germany 23 282 1.1× 184 1.1× 77 0.5× 247 1.5× 395 2.5× 57 1.2k
Stefan Rußwurm Germany 19 705 2.7× 224 1.3× 76 0.5× 196 1.2× 325 2.1× 35 1.4k
J Badoual France 20 328 1.3× 210 1.2× 35 0.2× 177 1.1× 185 1.2× 73 1.3k
Hideo Hosotsubo Japan 21 301 1.2× 357 2.1× 52 0.3× 180 1.1× 348 2.2× 49 1.2k
Dieter Fröhlich Germany 20 447 1.7× 356 2.1× 50 0.3× 404 2.5× 346 2.2× 58 1.6k
Iris Osberg United States 18 195 0.8× 128 0.8× 146 0.9× 124 0.8× 94 0.6× 25 1.2k

Countries citing papers authored by D Raichvarg

Since Specialization
Citations

This map shows the geographic impact of D Raichvarg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Raichvarg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Raichvarg more than expected).

Fields of papers citing papers by D Raichvarg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Raichvarg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Raichvarg. The network helps show where D Raichvarg may publish in the future.

Co-authorship network of co-authors of D Raichvarg

This figure shows the co-authorship network connecting the top 25 collaborators of D Raichvarg. A scholar is included among the top collaborators of D Raichvarg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Raichvarg. D Raichvarg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tallet, Frank, M.-P. Vasson, R. Couderc, Guillaume Lefèvre, & D Raichvarg. (1996). Characterization of lipoproteins during human cholestasis. Clinica Chimica Acta. 244(1). 1–15. 10 indexed citations
2.
Couderc, R., et al.. (1994). Effects of low-density lipoproteins on polymorphonuclear leukocyte functions in vitro.. PubMed. 10(3). 203–12. 6 indexed citations
3.
Roch-Arveiller, M, et al.. (1994). In vitro effect of cetirizine on PGE2 release by rat peritoneal macrophages and human monocytes. Inflammation Research. 43(1-2). 13–16. 18 indexed citations
4.
Vasson, M.-P., et al.. (1994). Effects of alpha-1 acid glycoprotein on human polymorphonuclear neutrophils: influence of glycan microheterogeneity. Clinica Chimica Acta. 224(1). 65–71. 57 indexed citations
5.
Meillet, D., Nathalie Kapel, Loïc Favennec, et al.. (1993). Correction factors for single radial immunodiffusion and electroimmunodiffusion assays of IgA in secretory fluids. Clinica Chimica Acta. 214(2). 235–241. 4 indexed citations
6.
Bailleul, S., et al.. (1993). Direct Phenotyping of Human Apolipoprotein E in Plasma: Application to Population Frequency Distribution in Paris (France). Human Heredity. 43(3). 159–165. 42 indexed citations
7.
Vasson, M.-P., et al.. (1993). Serum and Urinary Alpha-1 Acid Glycoprotein in Chronic Renal Failure. ˜The œNephron journals/Nephron journals. 65(2). 299–303. 28 indexed citations
8.
Favennec, Loïc, C. Chochillon, D. Meillet, et al.. (1992). A new screening assay for antigiardial compounds: effects of various drugs on the adherence ofGiardia duodenalis to Caco2 cells. Parasitology Research. 78(1). 80–81. 14 indexed citations
9.
Kapel, Nathalie, D. Meillet, Loïc Favennec, et al.. (1992). Evaluation of Intestinal Clearance and Faecal Excretion of α1-Antiproteinase and Immunoglobulins During Crohn’s Disease and Ulcerative Colitis. Clinical Chemistry and Laboratory Medicine (CCLM). 30(4). 197–202. 31 indexed citations
10.
Roch-Arveiller, M, et al.. (1991). Effect of an immunomodulating agent, RU 41740, on polymorphonuclear responsiveness after burn injury. Inflammation. 15(6). 437–445. 2 indexed citations
11.
Couderc, R., et al.. (1991). In Vitro Modulating Effect of Human Very-Low-Density Lipoproteins on Human Polymorphonuclear Leukocyte Oxidative Metabolism and Migration. Journal of Leukocyte Biology. 50(1). 1–9. 3 indexed citations
12.
Paul, J.L., et al.. (1991). Influence of Uremia on Polymorphonuclear Leukocytes Oxidative Metabolism in End-Stage Renal Disease and Dialyzed Patients. ˜The œNephron journals/Nephron journals. 57(4). 428–432. 30 indexed citations
13.
Meillet, D., et al.. (1991). [Intestinal humoral immunity and digestive opportunistic infections associated with AIDS].. PubMed. 185(1-2). 63–8.
14.
15.
Couderc, R., et al.. (1990). Effects of human low-density lipoproteins on human polymorphonuclear leucocytes in vitro. Biochemical Society Transactions. 18(6). 1188–1189. 4 indexed citations
16.
Kapel, Nathalie, D. Meillet, S Iscaki, et al.. (1990). Characterisation of the main molecular forms of human fecal immunoglobulin A. Clinica Chimica Acta. 195(1-2). 67–75. 4 indexed citations
17.
Favennec, Loïc, C. Chochillon, D. Meillet, et al.. (1990). Adherence and multiplication ofGiardia intestinalis on human enterocyte-like differentiated cells in vitro. Parasitology Research. 76(7). 581–584. 18 indexed citations
18.
Roch-Arveiller, M, et al.. (1988). In vitro and in vivo effects produced by the immunomodulating agent ru 41740 on human polymorphonuclear leukocytes in the elderly. Mechanisms of Ageing and Development. 44(3). 215–229. 2 indexed citations
19.
Roch-Arveiller, M, et al.. (1987). Effects exerted by RU 41740 on oxidative metabolism and migration of rat polymorphonuclear leukocytes collected after induction of one acute non specific inflammatory reaction. International Journal of Immunopharmacology. 9(4). 417–424. 10 indexed citations
20.
Raichvarg, D, et al.. (1978). Mise en évidence et dosage semi-automatique de la gélatine dans le sérum. Revue Franç aise de Transfusion et Immuno-hé matologie. 21(5). 1123–1129. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026